Alternative Names for Antidepressants in Bipolar II Disorder
Fluoxetine is also known by its brand name Prozac, and sertraline is also known as Zoloft—these are the two SSRIs with the most evidence supporting their use as monotherapy in bipolar II depression. 1, 2
Primary SSRI Options and Their Alternative Names
The second-generation antidepressants commonly used include both generic (chemical) names and brand (trade) names: 3
SSRIs (Selective Serotonin Reuptake Inhibitors):
- Fluoxetine = Prozac 3
- Sertraline = Zoloft 3
- Paroxetine = Paxil 3
- Citalopram = Celexa 3
- Escitalopram = Lexapro 3
- Fluvoxamine = Luvox 3
SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors):
Other Second-Generation Antidepressants:
Critical Context for Bipolar II Patients on Caplyta
For a patient with bipolar II disorder already taking Caplyta (lumateperone), fluoxetine monotherapy at 20 mg daily is the most evidence-based antidepressant choice, with demonstrated efficacy and a low manic switch rate of only 3.8-7.3%. 1, 2, 4
Why Fluoxetine Specifically for Bipolar II:
Fluoxetine monotherapy has been studied extensively in bipolar II depression with response rates of 38-48% and remarkably low hypomanic switch rates (3.8% during acute treatment, 2% during long-term therapy). 1, 2, 4
The manic switch rate with fluoxetine in bipolar II patients (3.8%) is not significantly different from unipolar depression patients (0.3-1%), challenging the traditional concern about antidepressant-induced mania in this population. 2
Fluoxetine demonstrated similar efficacy in bipolar II versus unipolar depression, with lower discontinuation rates for lack of efficacy (5% vs 12%) and similar adverse event profiles. 2
Important Safety Consideration:
Current treatment guidelines traditionally recommend mood stabilizer monotherapy or mood stabilizer plus SSRI combination for bipolar II depression due to manic switch concerns, but emerging evidence supports fluoxetine monotherapy as safe and effective with low switch rates. 1, 4 Since your patient is already on Caplyta (an atypical antipsychotic with mood-stabilizing properties), adding fluoxetine represents a rational combination approach. 5
Alternative Approved Combination:
The only FDA-approved antidepressant combination for bipolar depression is olanzapine/fluoxetine combination (brand name Symbyax), with NNT of 4-7 for response, though it carries significant weight gain risk (NNH of 6 for ≥7% weight gain). 5